Direct Meds Review: One Flat Price, and an FDA Letter

Direct Meds sells injectable sermorelin at $199 a month, and the number does not move: 30-day supply or 90-day, the monthly price is identical, with no membership and no separate consult fee. Almost every other seller we track uses the longer term to advertise a lower headline. This one does not — which is refreshing, and also means buying three months at once earns you nothing. It also received an FDA warning letter in September 2025.

The FDA warning letter

The FDA issued a warning letter to directmeds.com, Inc. dba DirectMeds in September 2025. We are saying so up front because the company appears in our sermorelin rankings and in our GLP-1 section, and we earn a commission when a reader starts care through some of our links. Read the letter before you give this company a card number: it is a public document, searchable by company name in the FDA's own database¹. We are not summarizing what it alleges — the agency's wording is the one that counts, and we have money in the outcome.

DirectMeds stays listed and its links stay live, with the letter and its date shown wherever the company appears. That is how we handle all three companies on this site in this position, and our methodology explains why: pulling a provider off a comparison page leaves you comparing a shorter market than the real one, and tells you nothing about the letter.

The flat price, and what it is not

Sermorelin is $199 a month here whether you buy 30 days or 90 — no bulk discount, no membership, no separate consult fee. The company markets it as "about $6.42 per day".

Read that honestly in both directions. It is genuinely straightforward: there is no commitment arithmetic to do, no prepay tier dangling a lower number, and none of the prepay-as-monthly confusion that makes some competitors' headlines so misleading. But a flat price is not automatically a good price — $199 sits at the top of the month-to-month range in our ranking, and buying three months at once earns you nothing at all, which is the opposite of how the rest of the category behaves. If you were going to commit to a quarter anyway, you are paying a premium for the privilege elsewhere and merely not being rewarded here. Our price-sorted ranking shows where $199 actually lands, and what sermorelin costs per month explains the spread.

Two things the product page does not publish: the mcg strength behind the $199, and which states it serves. Strength matters more than it sounds — a monthly price is only comparable against another monthly price at a comparable dose, and without the strength the figure is not fully checkable.

What it sells, and how the claims read

DirectMeds is a broad telehealth catalog — weight loss, anti-aging, skin, energy, hormone health, sexual health, pain relief, hair. Sermorelin is sold under the product name Sermorix as its own line item and not an add-on, which is better than the tier-floor pricing several competitors use.

Its sermorelin copy leads on the outcome this site cares about: "One of the first benefits users notice is deeper, more restful sleep." That ordering is defensible — sleep is the best-supported of sermorelin's marketed effects, since GHRH given to healthy men measurably increases slow-wave sleep alongside the expected growth-hormone release².

Two claims on the same page are weaker than the language suggests. "Clinically Proven Peptide Therapy" overstates what exists: sermorelin reliably moves GH and IGF-1 short-term, but there is no modern outcome trial demonstrating the body-composition or anti-aging benefits it is sold for³. And describing it as "a safer and more sustainable option" than synthetic HGH is a comparative safety claim without a comparative safety trial behind it. The mechanism argument for preferring a secretagogue is reasonable; calling the result proven and safer is not. Our pillar evidence guide sets out what the record actually supports, and sermorelin side effects covers the rest.

The GLP-1 side, and a number that does not add up

The same company appears in our GLP-1 section, because weight loss is the intervention with the strongest effect on obstructive sleep apnea — see GLP-1 for sleep apnea. Its published figures are injectable semaglutide $297/month, injectable tirzepatide $399/month, and sublingual semaglutide from $249/month. All compounded, so none is FDA-approved and none is the same product as Wegovy or Zepbound.

One checkable slip worth flagging, because it is the sort of thing that erodes confidence in every other figure on a site: the tirzepatide page prints "$9.58 per day" beside its $399 monthly price. $9.58 a day is the semaglutide figure ($297 across 31 days). At $399 the real per-day cost is closer to $13. It is a copy-paste error, not anything sinister, but it is on the page where the customer decides, and it understates the daily cost of the more expensive drug by about a third.

Bottom line

DirectMeds prices sermorelin simply and publishes it up front, sells it as a real product and not a tier floor, and leads its marketing with the benefit the evidence best supports. Against that: $199 is at the expensive end and the 90-day supply saves nothing, the strength and served states are unpublished, two of its efficacy claims are stronger than the evidence, its tirzepatide per-day figure is wrong on the page, and the FDA issued the company a warning letter in September 2025. Read the letter in the FDA's own database, and if you are comparing providers on price, compare at a stated dose — our where to buy sermorelin online page lays the options out.